GLP-3 R Retatrutide 30mg
Triple Agonist — Full Escalation Vial
Retatrutide 30mg — most practical vial for the complete triple agonist escalation protocol. Covers weeks 1-12 of the Phase II reference dosing schedule.
- Covers weeks 1-8 of complete escalation protocol from a single vial
- 24% body weight reduction in Phase II — outperforms all competitors
- Triple mechanism: GLP-1 + GIP + glucagon receptor agonism
- Glucagon agonism raises metabolic rate beyond dual agonists
- Phase III trials ongoing with highest expected peak efficacy
COA verified · US domestic shipping
Retatrutide 30mg: Most Efficient Vial for Triple Agonist Escalation Protocol
Full 8-Week Escalation
Covers weeks 1-8 from 2mg to 4mg/week — the most efficient single vial for starting the retatrutide protocol.
24% Outperforms All
Phase II: 24% weight reduction outperforms tirzepatide and semaglutide at comparable timepoints.
Glucagon Advantage
Third receptor adds hepatic fat burning and basal metabolic rate elevation — explaining the superior clinical data.
Phase III Pipeline
Most likely to become the highest-efficacy approved anti-obesity drug — Phase III data expected 2025-2026.
The Science Behind GLP-3 R Retatrutide 30mg
Retatrutide 30mg covers the complete initial escalation from 2mg to 8mg/week over the first 8 weeks. With 30mg, you run 4 weeks at 2mg (8mg total) and 4 weeks at 4mg (16mg total) — 24mg used, leaving 6mg for a bridging dose before moving to 60mg for high-dose maintenance.
Complete GLP-3 R Retatrutide 30mg Benefits
- Covers weeks 1-8 of complete escalation protocol from a single vial
- 24% body weight reduction in Phase II — outperforms all competitors
- Triple mechanism: GLP-1 + GIP + glucagon receptor agonism
- Glucagon agonism raises metabolic rate beyond dual agonists
- Phase III trials ongoing with highest expected peak efficacy
GLP-3 R Retatrutide 30mg Dosing Protocol
Full Escalation from 30mg:
• Reconstitute with 3mL bacteriostatic water (10mg/mL)
• Weeks 1-4: 2mg (0.2mL) weekly — 8mg used
• Weeks 5-8: 4mg (0.4mL) weekly — 24mg used
• Remaining 6mg bridges to 60mg vial
All information on this site is for educational purposes only. Always consult with a qualified healthcare provider before use. COA documentation is available from Apollo Peptide Sciences for all products.
Get GLP-3 R Retatrutide 30mg
Apollo Peptide Sciences — COA verified, US domestic, fast shipping.
Shop View Stack ProtocolsGLP receptor agonists work via hypothalamic appetite regulation and metabolic enhancement — proven in large-scale clinical trials.
All Weight Loss PeptidesStacks Best With
Stack GLP-3 R Retatrutide 30mg With
Anti-AgingNAD+ 500mg
Cellular Energy & Longevity Cofactor
NAD+ is the master cellular energy molecule that declines 50% by age 50 — supplementation restores sirtuin activity, DNA repair, and mitochondrial function.
Weight LossGLP-1 S (Semaglutide)
Next-Gen GLP-1 Receptor Agonist for Weight Loss
Semaglutide (GLP-1 S) is a GLP-1 receptor agonist with clinical trials showing 15-20% body weight reduction — the most effective pharmacological weight loss agent studied.
Weight LossGLP-2 T (Tirzepatide)
Dual GIP/GLP-1 Agonist — Superior Weight Loss
Tirzepatide (GLP-2 T) is a dual GIP/GLP-1 receptor agonist showing up to 22.5% body weight reduction in trials — outperforming semaglutide in head-to-head data.